March 6, 2014
 
 
 
    Email us   facebook   twitter   linkedin   YouTube icon
 
 
 

Calling all people living with lung cancer

  e-newsletter 030614 HOPE Summit image
   

LUNGevity is excited to be hosting our fourth annual national HOPE Summit, a lung cancer survivorship conference that connects people living with lung cancer from around the country. Sign up now! The summit will take place May 2-4 in Washington, DC, and will bring together survivors, medical experts, and others to celebrate survivorship and learn how to live well with lung cancer.

To better serve patients/survivors in their own communities, LUNGevity introduced regional HOPE Summits last fall. We now have regional HOPE Summits in Columbus, OH, and Dallas, TX, and will be introducing Seattle, WA, in August 2014.

To register for the national HOPE Summit, visit www.LUNGevity.org/HOPESummit; for more information, email HOPE@LUNGevity.org.

 

Listen to the experts talk about treatment advances

Promising advances and new directions in lung cancer treatment options are out there. Watch for new videos on the LUNGevity website to find out how researchers are hoping to save and improve lives. These videos will highlight the most important lung cancer news coming out of the International Association for the Study of Lung Cancer (IASLC) Targeted Therapies Meeting in February.

 

It's time to Breathe Deep

  e-newsletter 030614 BD image
   

Join the thousands of supporters coast to coast at one of LUNGevity’s Breathe Deep grassroots events. You’ll be part of a powerful lung cancer community raising awareness and funds for research, support, and education. There’s sure to be a walk or run near you. Coming up this spring are events in Michigan, California, Georgia, Virginia, Pennsylvania, Iowa, Ohio, and Illinois. Prefer an endurance event? Join Team LUNGevity. For more information about LUNGevity events, visit www.LUNGevity.org/events.

 

Researchers apply in record numbers for LUNGevity grants

It is fantastic that increasing numbers of scientists are choosing to make lung cancer their focus. Our reviewers—leaders in proteomics, radiology, biostatistics, immunotherapy, and other  relevant fields—will meet this May to review these Career Development, Early Detection, and Targeted Therapeutics proposals. We will announce the winners—the very best of these proposals—to you this summer. To read about the projects we are currently funding, visit www.LUNGevity.org/research.

 
 
 
 


Unsubscribe from receiving email, or change your email preferences.